ISMRM25 - Tumors & Contrast Agents

ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

Tumors & Contrast Agents

Weekend Course

ORGANIZERS: Xiaozhi Cao, Shoko Hara, Harpreet Hyare, Kenichi Oishi, Katharina Schregel, Leon Janse van Rensburg, Wietske van der Zwaag

Sunday, 11 May 2025

310 (Lili-u Theater)

13:15 - 17:15

Moderators: Akifumi Hagiwara & Jingwen Yao

Skill Level: Basic to Advanced

Session Number: WE-26

No CME/CE Credit

Session Number: WE-26

Overview
In the field of brain, head, and neck tumors, MRI is an essential tool for all clinical settings, such as pre-treatment diagnosis and assessments of treatment response. This course focuses on the new classification system, pre-treatment diagnosis, treatment, and post-treatment response of brain, head, and neck tumors.

Target Audience
This course targets researchers who want to update their knowledge about the diagnosis and treatment of brain tumors, and researchers/clinicians who want to update their knowledge of advanced MRI for preoperative evaluation.

Educational Objectives
As a result of attending this course, participants should be able to:
• Summarize the latest knowledge in brain, head & neck tumors;
• Summarize preoperative diagnosis using advanced MRI; and
• Identify treatment changes of brain tumors observed in MRI

13:15		New WHO Classification System of Brain Tumors View Presentation Video Katharina Wenger Impact: The WHO 2021 CNS tumor classification redefines diagnosis with integrated molecular markers; explore key diagnostic shifts, hallmark MRI features of adult & pediatric-type diffuse gliomas, and characteristics of selected newly recognized or revised CNS tumor entities beyond gliomas.
13:45		Update of WHO Head & Neck Tumors Classifications View Presentation Video Hirofumi Kuno Impact: WHO Head & Neck Tumor Classification (5th Ed) shifts from morphology to molecular taxonomy. This lecture explores MRI features of WHO updates, including HPV-related oropharyngeal SCC, SMARCB1-deficient and NUT sinonasal carcinomas, and salivary tumors with genetic alterations.
14:15		Imaging of Brain Tumors Using Contrast Materials Rajan Jain
14:45		Break & Meet the Teachers
15:15		Reduced Contrast Agent for Tumor Perfusion Evaluation Limin Zhou, Ananth Madhuranthakam
15:45		Non-Contrast Imaging for Tumor Evaluation View Presentation Video Ante Zhu Impact: Non-contrast contrast imaging reveals important tissue microstructural, molecular, and functional information of the heterogenous lesions in tumor. Leveraging these advanced MRI techniques is important for improved pre-surgical preparation and post-treatment evaluation.
16:15		Treatments of Brain Tumors View Presentation Video Manabu Kinoshita Impact: The current standard of care for gliomas encompasses surgical resection, radiation therapy, chemotherapy, molecular-targeted agents, and tumor-treating field therapy. This lecture aims to provide a comprehensive overview of the standard treatment options available for gliomas.
16:45		Imaging of Treatment Response of Brain Tumors Sahaja Acharya